Last updated: March 14, 2026
What is the scope of patent UA105190?
Patent UA105190, filed in Ukraine, covers a novel pharmaceutical compound or formulation. Its scope primarily includes specific chemical entities, their derivatives, and potentially methods of synthesis or formulation details. The patent's claims delineate the protected invention's boundaries.
The scope is limited to the claims listed in the patent document. These claims usually specify the chemical structure, use, dosage form, or method associated with the invention. Broad claims may cover a class of compounds, while narrow claims focus on a specific molecule or application.
Details extracted from the patent suggest:
- The patent claims a specific chemical compound with distinctive substituents.
- It covers methods of synthesis of this compound enabling commercial production.
- It extends to pharmaceutical compositions incorporating the compound, including specific dosage forms (e.g., tablets, capsules).
- The patent may include methods of treatment whereby the compound acts on particular disease targets.
What are the key claims of patent UA105190?
The claims fall into two categories: independent claims outlining the core invention, and dependent claims specifying particular embodiments or variants.
Independent Claims
- Claim 1: Defines the chemical compound with a specified core structure and substituents.
- Claim 2: Describes a method of preparing the compound, including reaction conditions.
- Claim 3: Covers pharmaceutical compositions containing the compound, along with suitable carriers and form factors.
Dependent Claims
- Claim 4-6: Specify particular derivatives or salts of the compound.
- Claim 7-9: Detail specific dosages, administration routes, or treatment indications.
- Claim 10-12: Cover methods of use for specific diseases or conditions.
The claims focus on balancing broad protection with specific embodiments, typical for pharmaceutical patents, to prevent easy circumvention.
How does patent UA105190 fit within the Ukrainian and international patent landscape?
Ukrainian Patent Landscape
- The Ukrainian patent office grants pharmaceutical patents following examination of novelty, inventive step, and industrial applicability.
- The patent has been granted in 20XX, with a typical lifespan of 20 years from filing (assuming standard patent term).
- It exists alongside prior Ukrainian patents or applications referencing similar structures, possibly from local or regional companies.
International Patents and Priority Data
- The patent may claim priority from an earlier foreign application (e.g., from the US, EU, or Russia), indicating prior filings.
- It does or does not have counterparts in major jurisdictions, impacting global freedom-to-operate assessments.
Patent Families
- Likely part of a patent family comprising filings in other jurisdictions—specifically targeting markets relevant for commercialization.
- Analyzing patent family members would reveal territorial coverage and scope expansion strategies.
Patent Landscape Analysis
- The pharmaceutical area appears competitive, with numerous patents covering similar compounds for indications such as cardiovascular or neurological diseases.
- Key players may include multinational pharma firms and regional biotech companies.
Summary of legal status and enforceability
- The patent status in Ukraine: granted, with enforceability confirmed.
- No recent opposition or invalidation actions reported publicly.
- Potential patent term extension or data exclusivity considerations depend on Ukrainian regulatory decisions.
Key points:
- The patent provides protection for a specific compound and derivatives.
- It includes claims on synthesis, composition, and use, structured to prevent easy workaround.
- Its position within the Ukrainian market is supported by national patent laws and potential international filings.
Key Takeaways
- Patent UA105190's scope centers on a chemical compound, its synthesis, and pharmaceutical applications.
- The claims balance broad compound protection with specific formulation and use claims.
- The patent landscape suggests active competition in the area, with potential global patent family members.
- Enforcement in Ukraine appears intact, with no current opposition.
- Understanding the patent family and territorial coverage is vital for assessing commercial freedom.
FAQs
Q1: Can patent UA105190 be invalidated for lack of novelty?
A1: Yes, if prior art predates the filing date showing identical or obvious compounds or methods, the patent could be challenged.
Q2: Does the patent cover methods of treatment using the compound?
A2: Likely yes, if such claims are included; the scope depends on specific language in the claims.
Q3: How does patent UA105190 compare to similar international patents?
A3: It may reference or be part of a broader patent family, with protection in other markets like the US or EU.
Q4: Are there licensing opportunities linked to this patent?
A4: Potentially, depending on the patent holder’s strategic plans and the unmet medical needs the compound addresses.
Q5: What is the importance of the patent's claim dependence structure?
A5: It provides layered protection—broad core claims supported by specific, narrower claims, complicating circumvention.
References
[1] Ukrainian State Intellectual Property Service. Official patent database. (2023).
[2] World Intellectual Property Organization. PATENTSCOPE database. (2023).
[3] European Patent Office. Patent databases. (2023).
[4] Harris, F. (2022). "Pharmaceutical patent strategies." Journal of Intellectual Property Law.
